Literature DB >> 27982579

Lipidomics Characterization of Biosynthetic and Remodeling Pathways of Cardiolipins in Genetically and Nutritionally Manipulated Yeast Cells.

Yulia Y Tyurina, Wenjia Lou1, Feng Qu, Vladimir A Tyurin, Dariush Mohammadyani2, Jenney Liu3, Maik Hüttemann3, Michael A Frasso, Peter Wipf, Hülya Bayir, Miriam L Greenberg1, Valerian E Kagan.   

Abstract

pan class="Chemical">Cardioipinsn> (CLs) are unique tetra-acylated phospholipids of mitochondria and define the bioenergetics and regulatory functions of these organelles. An unresolved paradox is the high uniformity of CL molecular species (tetra-linoleoyl-CL) in the heart, liver, and skeletal muscles-in contrast to their high diversification in the brain. Here, we combined liquid chromatography-mass-spectrometry-based phospholipidomics with genetic and nutritional manipulations to explore CLs' biosynthetic vs postsynthetic remodeling processes in S. cerevisiae yeast cells. By applying the differential phospholipidomics analysis, we evaluated the contribution of Cld1 (CL-specific phospholipase A) and Taz1 (acyl-transferase) as the major regulatory mechanisms of the remodeling process. We further established that nutritional "pressure" by high levels of free fatty acids triggered a massive synthesis of homoacylated molecular species in all classes of phospholipids, resulting in the preponderance of the respective homoacylated CLs. We found that changes in molecular speciation of CLs induced by exogenous C18-fatty acids (C18:1 and C18:2) in wild-type (wt) cells did not occur in any of the remodeling mutant cells, including cld1Δ, taz1Δ, and cld1Δtaz1Δ. Interestingly, molecular speciation of CLs in wt and double mutant cells cld1Δtaz1Δ was markedly different. Given that the bioenergetics functions are preserved in the double mutant, this suggests that the accumulated MLCL-rather than the changed CL speciation-are the likely major contributors to the mitochondrial dysfunction in taz1Δ mutant cells (also characteristic of Barth syndrome). Biochemical studies of Cld1 specificity and computer modeling confirmed the hydrolytic selectivity of the enzyme toward C16-CL substrates and the preservation of C18:1-containing CL species.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27982579      PMCID: PMC5578713          DOI: 10.1021/acschembio.6b00995

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  45 in total

1.  Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

Authors:  Zhiming Gu; Fredoen Valianpour; Shuliang Chen; Frederic M Vaz; Gertjan A Hakkaart; Ronald J A Wanders; Miriam L Greenberg
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

2.  Scoring function for automated assessment of protein structure template quality.

Authors:  Yang Zhang; Jeffrey Skolnick
Journal:  Proteins       Date:  2004-12-01

3.  Monolysocardiolipin: improved preparation with high yield.

Authors:  Junhwan Kim; Charles L Hoppel
Journal:  J Lipid Res       Date:  2010-10-19       Impact factor: 5.922

4.  [Participation of phospholipases in the "repair" of photoreceptor membranes subjected to peroxidation].

Authors:  V E Kagan; A A Shvedova; K N Novikov
Journal:  Biofizika       Date:  1978 Mar-Apr

5.  Cardiolipin synthase expression is essential for growth at elevated temperature and is regulated by factors affecting mitochondrial development.

Authors:  F Jiang; Z Gu; J M Granger; M L Greenberg
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

Review 6.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update.

Authors:  Peter G Barth; Fredoen Valianpour; Valerie M Bowen; Jan Lam; Marinus Duran; Frédéric M Vaz; Ronald J A Wanders
Journal:  Am J Med Genet A       Date:  2004-05-01       Impact factor: 2.802

7.  Shorthand notation for lipid structures derived from mass spectrometry.

Authors:  Gerhard Liebisch; Juan Antonio Vizcaíno; Harald Köfeler; Martin Trötzmüller; William J Griffiths; Gerd Schmitz; Friedrich Spener; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2013-04-02       Impact factor: 5.922

8.  Barth syndrome mutations that cause tafazzin complex lability.

Authors:  Steven M Claypool; Kevin Whited; Santi Srijumnong; Xianlin Han; Carla M Koehler
Journal:  J Cell Biol       Date:  2011-02-07       Impact factor: 10.539

9.  Cardiac metabolic pathways affected in the mouse model of barth syndrome.

Authors:  Yan Huang; Corey Powers; Satish K Madala; Kenneth D Greis; Wendy D Haffey; Jeffrey A Towbin; Enkhsaikhan Purevjav; Sabzali Javadov; Arnold W Strauss; Zaza Khuchua
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  A mitochondrial pathway for biosynthesis of lipid mediators.

Authors:  Yulia Y Tyurina; Samuel M Poloyac; Vladimir A Tyurin; Alexander A Kapralov; Jianfei Jiang; Tamil Selvan Anthonymuthu; Valentina I Kapralova; Anna S Vikulina; Mi-Yeon Jung; Michael W Epperly; Dariush Mohammadyani; Judith Klein-Seetharaman; Travis C Jackson; Patrick M Kochanek; Bruce R Pitt; Joel S Greenberger; Yury A Vladimirov; Hülya Bayır; Valerian E Kagan
Journal:  Nat Chem       Date:  2014-04-20       Impact factor: 24.427

View more
  8 in total

1.  Assembly of the complexes of oxidative phosphorylation triggers the remodeling of cardiolipin.

Authors:  Yang Xu; Murari Anjaneyulu; Alec Donelian; Wenxi Yu; Miriam L Greenberg; Mindong Ren; Edward Owusu-Ansah; Michael Schlame
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

2.  The Basis for Acyl Specificity in the Tafazzin Reaction.

Authors:  Michael Schlame; Yang Xu; Mindong Ren
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

Review 3.  Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.

Authors:  Jiajia Ji; Miriam L Greenberg
Journal:  J Inherit Metab Dis       Date:  2021-10-19       Impact factor: 4.982

4.  Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome.

Authors:  Zhuqing Liang; Michael W Schmidtke; Miriam L Greenberg
Journal:  Front Mol Biosci       Date:  2022-05-27

5.  Genetic re-engineering of polyunsaturated phospholipid profile of Saccharomyces cerevisiae identifies a novel role for Cld1 in mitigating the effects of cardiolipin peroxidation.

Authors:  Wenjia Lou; Hsiu-Chi Ting; Christian A Reynolds; Yulia Y Tyurina; Vladimir A Tyurin; Yiran Li; Jiajia Ji; Wenxi Yu; Zhuqing Liang; Detcho A Stoyanovsky; Tamil S Anthonymuthu; Michael A Frasso; Peter Wipf; Joel S Greenberger; Hülya Bayır; Valerian E Kagan; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-20       Impact factor: 4.698

6.  Disentangling oxidation/hydrolysis reactions of brain mitochondrial cardiolipins in pathogenesis of traumatic injury.

Authors:  Honglu Chao; Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew A Amoscato; Laura K Cole; Grant M Hatch; Jing Ji; Valerian E Kagan; Hülya Bayır
Journal:  JCI Insight       Date:  2018-11-02

Review 7.  Regulation of lipid peroxidation and ferroptosis in diverse species.

Authors:  Marcus Conrad; Valerian E Kagan; Hülya Bayir; Gabriela C Pagnussat; Brian Head; Maret G Traber; Brent R Stockwell
Journal:  Genes Dev       Date:  2018-05-01       Impact factor: 11.361

8.  Adaptive response to wine selective pressures shapes the genome of a Saccharomyces interspecies hybrid.

Authors:  María Lairón-Peris; Gabriel L Castiglioni; Sarah J Routledge; Javier Alonso-Del-Real; John A Linney; Andrew R Pitt; Josef Melcr; Alan D Goddard; Eladio Barrio; Amparo Querol
Journal:  Microb Genom       Date:  2021-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.